CGTLimited DatastaleShanghai Cell Therapy Group Co.…Phase 1
BZE2204 (CD19/CD22/BCMA CAR-T cells, CD19/CD22/BCMA CAR-T cells(BZE2204))
Idiopathic Inflammatory Myopathies(IIM); Immune Thrombocytopenia(ITP) · CD19
#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting